4.6 Article

A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3,5,3′,4′-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study

Journal

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 51, Issue 3, Pages 679-684

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2009.09.024

Keywords

HPLC-UV; Pharmacokinetics; trans-3,5,3 ',4 '-Tetramethoxystilbene; Piceatannol; Oral bicavailability

Funding

  1. Agency for Science, Technology and Research, Republic of Singapore [BMRC 06/1/21/19/441]
  2. Universita degli Studi di Catania (Progetti di Ricerca di Ateneo, Catania, Italy)
  3. MIUR, Ministero dell'Universita e della Ricerca (Rome, Italy)

Ask authors/readers for more resources

A simple and sensitive HPLC-UV method was developed and validated for the quantification of piceatannol analog trans-3,5,3',4'-tetramethoxystilbene (M-PIC) in rat plasma. Following protein precipitation with three volumes of acetonitrile, the analytes were separated on a RP-HPLC column, which was protected by a guard column through gradient delivery of a mixture of acetonitrile-water at 40 degrees C. The UV absorbance at 325 nm was recorded to quantify M-PIC. The retention time of M-PIC and trans-3,5-dimethoxystilbene (internal standard) was 7.4 and 8.4 min, respectively. The calibration curves were linear (R(2) > 0.9989) with a lower limit of quantification of 15 ng/ml. The intra- and inter-day precisions, in terms of RSD, were all lower than 7.5%. The average analytical recovery ranged from 97.0 to 104.3% while the average absolute recovery ranged from 101.8 to 105.0%. This reliable HPLC method was subsequently applied to assess the pharmacokinetic profile of M-PIC in Sprague-Dawley rats using 2-hydroxypropyl-beta-cyclodextrin as a dosing vehicle. The terminal elimination half-life (t(1/2 lambda z)) and clearance (Cl) of M-PIC were 313 +/- 20 min and 33.1 +/- 3.9 ml/min/kg, respectively: and its absolute oral bioavailability was as high as 50.7 +/- 15.0%. M-PIC appeared to have a favorable pharmacokinetic profile and further pharmacological investigation on this phyto-stilbene was warranted. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available